Machine learning to predict post-therapy dosimetry for 177Lu-PSMA I&T treatment

被引：0
|
作者：
Shi, K. [1 ]
Xue, S. [1 ]
Gafita, A. [2 ]
Dong, C. [2 ]
Zhao, Y. [2 ]
Tetteh, G. [2 ]
Menze, B. H. [2 ]
Afshar-Oromieh, A. [1 ]
Eiber, M. [2 ]
Rominger, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-441
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [21] Radiation dosimetry for 177Lu-PSMA I&T therapy in metastatic prostate cancer: results for normal organs, tumor lesions and comparison between different cycles
    Okamoto, Shozo
    Thieme, Anne
    Allmann, Jakob
    Maurer, Tobias
    Retz, Margitta
    Tauber, Robert
    Heck, Matthias
    Wester, Hans-Juergen
    Tamaki, Nagara
    Scheidhauer, Klemens
    Schwaiger, Markus
    Ziegler, Sibylle
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [22] Value of post-therapy 177Lu-PSMA images for accurate interpretation of therapy response with 68Ga-PSMA PET/CT
    Tuncel, M.
    Telli, T.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 114 - 117
  • [23] Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry
    Schuchardt, Christiane
    Zhang, Jingjing
    Kulkarni, Harshad R.
    Chen, Xiaoyuan
    Mueller, Dirk
    Baum, Richard P.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1199 - 1207
  • [24] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [25] Improved quality control of [177Lu]Lu-PSMA I&T
    Martin Kraihammer
    Piotr Garnuszek
    Andreas Bauman
    Michael Maurin
    Manuel Alejandre Lafont
    Roland Haubner
    Elisabeth von Guggenberg
    Michael Gabriel
    Clemens Decristoforo
    EJNMMI Radiopharmacy and Chemistry, 8
  • [26] Organ-regularized Deep Learning for Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu PSMA Therapy
    Xue, Song
    Gafita, Andrei
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Rominger, Axel
    Shi, Kuangyu
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [27] Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results
    Acar, Emine
    Sonmezer, Burak
    Derebek, Erkan
    Bekis, Recep
    Ozdogan, Ozhan
    Kaya, Gamze Capa
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03): : 158 - 164
  • [28] Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
    Okamoto, Shozo
    Thieme, Anne
    Allmann, Jakob
    D'Alessandria, Calogero
    Maurer, Tobias
    Retz, Margitta
    Tauber, Robert
    Heck, Matthias M.
    Wester, Hans-Juergen
    Tamaki, Nagara
    Fendler, Wolfgang P.
    Herrmann, Ken
    Pfob, Christian H.
    Scheidhauer, Klemens
    Schwaiger, Markus
    Ziegler, Sibylle
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 445 - 450
  • [29] Optimising the Synthesis and QC of [177Lu]Lu-PSMA I&T for Prostate Cancer Therapy
    Hong, K.
    Fincher, L.
    Browne, E.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 53 - 54
  • [30] Influence of patient motion on image-based dosimetry for 177Lu-PSMA therapy
    Resch, S.
    Rumiantcev, M.
    Liubchenko, G.
    Brendel, M.
    Ziegler, S. I.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S211 - S211
12345